{"id":2745,"date":"2020-08-17T13:39:49","date_gmt":"2020-08-17T17:39:49","guid":{"rendered":"http:\/\/localhost:10028\/whitepapers\/law360-hunter-shkolnik-questions-former-fda-commissioner\/"},"modified":"2022-06-27T02:40:02","modified_gmt":"2022-06-27T06:40:02","slug":"law360-hunter-shkolnik-questions-former-fda-commissioner","status":"publish","type":"whitepapers","link":"https:\/\/www.napolilaw.com\/es\/libros-blancos\/law360-hunter-shkolnik-questions-former-fda-commissioner\/","title":{"rendered":"Law360: Hunter Shkolnik cuestiona al ex comisionado de la FDA"},"content":{"rendered":"<p>The (opioid) trial is expected to test allegations from New York and Suffolk and Nassau counties against major drug manufacturers and distributors.<\/p>\n<p>The so-called Frye hearings in the suit are used to determine the admissibility of scientific evidence.<\/p>\n<p>&#8220;Would it be fair to say that you determined there were departures from the appropriate standards of marketing and promotion?&#8221; Hunter Shkolnik of Napoli Shkolnik PLLC, representing Nassau County, asked.<\/p>\n<p>Kessler replied that he had.<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Se espera que el juicio (opioide) pruebe las acusaciones de los condados de Nueva York y Suffolk y Nassau contra los principales fabricantes y distribuidores de medicamentos. Las llamadas audiencias de Frye en la demanda son...<\/p>","protected":false},"featured_media":0,"menu_order":144,"template":"","whitepaper_category":[57,75,101,253,254],"whitepaper-source":[63],"class_list":["post-2745","whitepapers","type-whitepapers","status-publish","hentry","whitepaper_category-hunter-shkolnik","whitepaper_category-opioids-litigation","whitepaper_category-new-york-opioid-lawyers","whitepaper_category-opioid-crisis","whitepaper_category-opioid-epidemic","whitepaper-source-law360"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.napolilaw.com\/es\/wp-json\/wp\/v2\/whitepapers\/2745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.napolilaw.com\/es\/wp-json\/wp\/v2\/whitepapers"}],"about":[{"href":"https:\/\/www.napolilaw.com\/es\/wp-json\/wp\/v2\/types\/whitepapers"}],"version-history":[{"count":0,"href":"https:\/\/www.napolilaw.com\/es\/wp-json\/wp\/v2\/whitepapers\/2745\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.napolilaw.com\/es\/wp-json\/wp\/v2\/media?parent=2745"}],"wp:term":[{"taxonomy":"whitepaper_category","embeddable":true,"href":"https:\/\/www.napolilaw.com\/es\/wp-json\/wp\/v2\/whitepaper_category?post=2745"},{"taxonomy":"whitepaper-source","embeddable":true,"href":"https:\/\/www.napolilaw.com\/es\/wp-json\/wp\/v2\/whitepaper-source?post=2745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}